Bronnen:
Franz DN, Lawson J, Yapici Z, et al. Long-term efficacy and safety of everolimus as adjuctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment -refractory seizures: Final analysis of the EXIST-3 study. EAN 2018, abstract O424.,Franz DN, Lawson JA, Yapici Z, et al. Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures. Epilepsia. 2018;59:1188-97.
Franz DN, Lawson J, Yapici Z, et al. Long-term efficacy and safety of everolimus as adjuctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment -refractory seizures: Final analysis of the EXIST-3 study. EAN 2018, abstract O424.,Franz DN, Lawson JA, Yapici Z, et al. Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures. Epilepsia. 2018;59:1188-97.